A guide to immunotherapy for COVID-19

被引:227
作者
van de Veerdonk, Frank L. [1 ,2 ]
Giamarellos-Bourboulis, Evangelos [3 ]
Pickkers, Peter [4 ,5 ]
Derde, Lennie [6 ]
Leavis, Helen [7 ]
van Crevel, Reinout [1 ,2 ]
Engel, Job J. [1 ,2 ]
Wiersinga, W. Joost [8 ]
Vlaar, Alexander P. J. [9 ,10 ]
Shankar-Hari, Manu [11 ]
van der Poll, Tom [8 ]
Bonten, Marc [12 ]
Angus, Derek C. [13 ,14 ]
van der Meer, Jos W. M. [1 ,2 ]
Netea, Mihai G. [1 ,2 ,15 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands
[3] Univ Athens, Attikon Hosp, Dept Infect Dis, Athens, Greece
[4] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands
[6] Univ Med Ctr Utrecht, Dept Intens Care, Utrecht, Netherlands
[7] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands
[8] Univ Amsterdam, Amsterdam UMC, Ctr Expt Mol Med CEMM, Div Infect Dis, Amsterdam, Netherlands
[9] Univ Amsterdam, Amsterdam UMC, Dept Intens Care Med, Amsterdam, Netherlands
[10] Univ Amsterdam, Amsterdam UMC, Lab Expt Intens Care Med & Anesthesiol, Amsterdam, Netherlands
[11] Kings Coll London, Sch Immunobiol & Microbial Sci, London, England
[12] Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[13] UPMC, Pittsburgh, PA USA
[14] Univ Pittsburgh, Pittsburgh, PA USA
[15] Univ Bonn, Life & Med Sci Inst, Dept Immunol & Metab, Bonn, Germany
关键词
KINASE INHIBITORS; TISSUE FACTOR; OPEN-LABEL; MULTICENTER; NEUTROPHILS; THROMBOSIS; IMMUNITY; C5A;
D O I
10.1038/s41591-021-01643-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This Review aims to support clinical decision-making by providing an overview of the evidence for immunotherapy strategies in patients with COVID-19. Immune dysregulation is an important component of the pathophysiology of COVID-19. A large body of literature has reported the effect of immune-based therapies in patients with COVID-19, with some remarkable successes such as the use of steroids or anti-cytokine therapies. However, challenges in clinical decision-making arise from the complexity of the disease phenotypes and patient heterogeneity, as well as the variable quality of evidence from immunotherapy studies. This Review aims to support clinical decision-making by providing an overview of the evidence generated by major clinical trials of host-directed therapy. We discuss patient stratification and propose an algorithm to guide the use of immunotherapy strategies in the clinic. This will not only help guide treatment decisions, but may also help to design future trials that investigate immunotherapy in other severe infections.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 104 条
  • [71] Patel J., RANDOMIZED TRIAL OTI, DOI [10.1101/2021.04.14.21255475(2021, DOI 10.1101/2021.04.14.21255475(2021]
  • [72] A Longitudinal Study of Immune Cells in Severe COVID-19 Patients
    Payen, Didier
    Cravat, Maxime
    Maadadi, Hadil
    Didelot, Carole
    Prosic, Lydia
    Dupuis, Claire
    Losser, Marie-Reine
    De Carvalho Bittencourt, Marcelo
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [73] Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
    Pouletty, Marie
    Borocco, Charlotte
    Ouldali, Naim
    Caseris, Marion
    Basmaci, Romain
    Lachaume, Noemie
    Bensaid, Philippe
    Pichard, Samia
    Kouider, Hanane
    Morelle, Guillaume
    Craiu, Irina
    Pondarre, Corinne
    Deho, Anna
    Maroni, Arielle
    Oualha, Mehdi
    Amoura, Zahir
    Haroche, Julien
    Chommeloux, Juliette
    Bajolle, Fanny
    Beyler, Constance
    Bonacorsi, Stephane
    Carcelain, Guislaine
    Kone-Paut, Isabelle
    Bader-Meunier, Brigitte
    Faye, Albert
    Meinzer, Ulrich
    Galeotti, Caroline
    Melki, Isabelle
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (08) : 999 - 1006
  • [74] Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital
    Ramcharan, Tristan
    Nolan, Oscar
    Lai, Chui Yi
    Prabhu, Nanda
    Krishnamurthy, Raghu
    Richter, Alex G.
    Jyothish, Deepthi
    Kanthimathinathan, Hari Krishnan
    Welch, Steven B.
    Hackett, Scott
    Al-Abadi, Eslam
    Scholefield, Barnaby R.
    Chikermane, Ashish
    [J]. PEDIATRIC CARDIOLOGY, 2020, 41 (07) : 1391 - 1401
  • [75] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Richeldi, Luca
    Kolb, Martin
    Jouneau, Stephane
    Wuyts, Wim A.
    Schinzel, Birgit
    Stowasser, Susanne
    Quaresma, Manuel
    Raghu, Ganesh
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [76] Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    Costabel, Ulrich
    Selman, Moises
    Kim, Dong Soon
    Hansell, David M.
    Nicholson, Andrew G.
    Brown, Kevin K.
    Flaherty, Kevin R.
    Noble, Paul W.
    Raghu, Ganesh
    Brun, Michele
    Gupta, Abhya
    Juhel, Nolwenn
    Klueglich, Matthias
    du Bois, Roland M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) : 1079 - 1087
  • [77] Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience
    Riollano-Cruz, Mariawy
    Akkoyun, Esra
    Briceno-Brito, Eudys
    Kowalsky, Shanna
    Reed, James
    Posada, Roberto
    Sordillo, Emilia Mia
    Tosi, Michael
    Trachtman, Rebecca
    Paniz-Mondolfi, Alberto
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 424 - 433
  • [78] A novel c5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways
    Ritis, Konstantinos
    Doumas, Michael
    Mastellos, Dimitrios
    Micheli, Anastasia
    Giaglis, Stavros
    Magotti, Paola
    Rafail, Stavros
    Kartalis, Georgios
    Sideras, Paschalis
    Lambris, John D.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (07) : 4794 - 4802
  • [79] Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
    Rovina, Nikoletta
    Akinosoglou, Karolina
    Eugen-Olsen, Jesper
    Hayek, Salim
    Reiser, Jochen
    Giamarellos-Bourboulis, Evangelos J.
    [J]. CRITICAL CARE, 2020, 24 (01)
  • [80] Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
    Ruscitti, Piero
    Berardicurti, Onorina
    Di Benedetto, Paola
    Cipriani, Paola
    Iagnocco, Annamaria
    Shoenfeld, Yehuda
    Giacomelli, Roberto
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11